DMAC
DiaMedica Therapeutics Inc

1,551
Loading...
Loading...
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
28

Frequently Asked Questions

What is Market Cap of DiaMedica Therapeutics Inc?
What is the 52-week high for DiaMedica Therapeutics Inc?
What is the 52-week low for DiaMedica Therapeutics Inc?
What is DiaMedica Therapeutics Inc stock price today?
What was DiaMedica Therapeutics Inc stock price yesterday?
What is the PE ratio of DiaMedica Therapeutics Inc?
What is the Price-to-Book ratio of DiaMedica Therapeutics Inc?
What is the 50-day moving average of DiaMedica Therapeutics Inc?
How many employess does DiaMedica Therapeutics Inc has?

Latest DMAC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.